EVs and EPS in Cancer: Cell-to-Cell Communication, Diagnosis, and Evaluation of Cancer Therapy Response
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 20 July 2025 | Viewed by 2191
Special Issue Editors
Interests: extracellular vesicles; EV
Interests: genetics; biomarkers; prostate cancer; gynecological cancer; sarcoma; biobanking; breast cancer; molecular pathology; extracellular vesicles
Special Issue Information
Dear Colleagues,
Extracellular vesicles (EVs) and Particles (EPs) play essential roles in intercellular signaling in cancers. Interest in EVs increased dramatically after the discovery that EVs could transfer nucleic acids like RNA from cell to cell. Associated with EVs from certain cells or tissues, nucleic acids could be easily amplified as markers of tumor cells. When EVs are taken up by other cells, they may alter the behavior of the recipient cell. Thus, EVs are of importance in forming tumor landscapes.
This Special Issue is aimed at understanding not only EV-based cell-to-cell communication in cancers but also EVs and EPs in the diagnosis of cancers and evaluation of the therapy response. Topics of interest may range from the application of EVs in liquid biopsy to the latest technology and discovery of EVs to characterize cancer cells. Original research papers and review articles in related fields are welcomed.
Prof. Dr. Irina Nazarenko
Dr. José Antonio López-Guerrero
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles
- EVs
- particles
- cancer
- liquid biopsy
- cell-cell communication
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
